Skip to search formSkip to main contentSkip to account menu

Fenofibrate 160 MG Oral Tablet

Known as: FENOFIBRATE 160MG TAB [VA Product], FENOFIBRATE 160 mg in 30 oral TABLET, FENOFIBRATE 160 mg ORAL TABLET, FILM COATED [Fenofibrate] 
National Institutes of Health

Related topics

Related topics

46 relations

Broader (1)

Antilipemic agent
Biliary cirrhosisCoronary Artery DiseaseCroscarmellose SodiumDecreased Lipolysis [PE]

Narrower (1)

Fenofibrate 160 MG Oral Tablet [Triglide]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Micronised Fenofibrate
SummaryAbstractMicronised fenofibrate is a synthetic phenoxy-isobutyric acid derivative (fibric acid derivative) indicated for… 
2003
2003
The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease.
2002
2002
The Effects of the Addition of Micronised Fenofibrate on Uric Acid Metabolism in Patients Receiving Indapamide
Summary Objective: Hyperuricaemia is associated with indapamide administration. In contrast, micronised fenofibrate can… 
2001
2001
Benefits of micronised Fenofibrate in type 2 diabetes mellitus subjects with good glycemic control.
Highly Cited
2000
Highly Cited
2000
Efficacy of combination of atorvastatin and micronised fenofibrate in the treatment of severe mixed hyperlipidemia
Abstract. Objectives: In patients with mixed lipid disorders, monotherapy may not effectively control all lipid abnormalities. We… 
2000
2000
Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.
The aim of this study was to evaluate the efficacy on LDL-cholesterol (LDL-C) of micronised fenofibrate given for three months at… 
Highly Cited
1999
Highly Cited
1999
Atherogenic lipoprotein phenotype in Type 2 diabetes: reversal with micronised fenofibrate
To assess the short‐term effects of a micronised formulation of fenofibrate on lipids, lipoproteins and their composition… 
1998
1998
Effectiveness and Tolerability of 12-Week Treatment with Micronised Fenofibrate 200mg in a Drug-Monitoring Programme Involving 9884 Patients with Dyslipidaemia
SummaryFollowing the introduction of micronised fenofibrate (Laboratoires Fournier, Dijon), a new formulation of fenofibrate with… 
Review
1997
Review
1997
Micronised Fenofibrate
SummarySynopsisMicronised fenofibrate is a new formulation of the fibric acid derivative fenofibrate. It is indicated for the… 
1997
1997
Comparative effects of bezafibrate and micronised fenofibrate in patients with type III hyperlipoproteinemia.
Type III hyperlipoproteinemia (HLP) is characterized by elevated concentrations of plasma cholesterol and triglycerides due to an… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)